Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,216.00    38.00 (1.74%)
Bid:
2,220.00
Ask:
2,228.00
Spread: 8.00 (0.36%)
Market Cap: £1.47b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

27 Sep 2013 18:19

RNS Number : 1785P
Genus PLC
27 September 2013
 



27 September 2013

 

Genus plc

("Genus" or the "Company")

 

Director/PDMR Shareholdings

 

Genus announces that conditional nil-cost share options were granted yesterday under the Genus 2004 Performance Share Plan (the "PSP") to:

 

· Karim Bitar, Chief Executive, as to 73,107 ordinary shares of 10 pence each in the Company ("Shares");

 

· Stephen Wilson, Group Finance Director, as to 43,347 Shares;

 

· Bill Christianson, Chief Operating Officer, Genus PIC, as to 22,520 Shares;

 

· Saskia Korink Romani, Chief Operating Officer, Genus ABS, as to 18,887 Shares;

 

· Jerry Thompson, Chief Operating Officer, Genus Asia, as to 21,231 Shares;

 

· Denny Funk, Chief Scientific Officer, as to 16,559 Shares;

 

· Catherine Glickman, Group Human Resources Director, as to 21,762 Shares; and

 

· Tom Kilroy, Group General Counsel & Company Secretary as to 26,539 Shares

 

Under the PSP, the Share options that have been granted are subject to challenging performance conditions that relate to the growth in the Company's adjusted earnings per share over a three year performance period and which trigger vesting on an incremental basis. More demanding performance targets apply to the portion of the Share options granted that exceed 125% of salary for the Chief Executive and 100% of salary for the other PSP participants listed above. Details of the performance conditions that apply to the Share options can be found in the Directors' Remuneration Report of the Company's Annual Report & Accounts.

 

Genus further announces that:

 

· 9,552 ordinary shares of 10 pence each in the Company ("Share(s)") were today sold on behalf of Bill Christianson, Chief Operating Officer, Genus PIC, at a price of 1,430 pence per Share. This sale was made further to the vesting of 24,418 conditional nil cost Share options on 11 September 2013 under the Company's Performance Share Plan (the "PSP"). The remaining exercised 14,866 Share options that vested under the PSP in September 2013 have been retained by Bill Christianson.

 

· on behalf of Jerry Thompson, Chief Operating Officer, Genus Asia:

 

o 16,452 Shares were today sold at a price of 1,430 pence per Share. This sale was made further to the vesting of 21,452 nil cost Share options on 11 September 2013 under the PSP; and

 

o 5,054 Shares were today sold at a price of 1,430 pence per Share. This sale was made further to the vesting of 18,640 market value Share options on 17 September 2012 under the Company's Executive Share Option Plan (the "ESOP").

 

Karim Bitar's direct shareholding in the Company stands at 36,963 Shares representing 0.061% of the issued share capital of the Company that is currently 60,665,678 Shares. In addition, he is the beneficial owner of 212,445 conditional nil-cost Share options.

 

Stephen Wilson's direct shareholding stands at 3,000 Shares representing 0.005% of the issued share capital of the Company. In addition, he is the beneficial owner of 86,410 conditional nil-cost Share options under the PSP.

 

Bill Christianson's direct shareholding stands at 14,287 Shares representing 0.024% of the issued share capital of the Company. In addition, he is the beneficial owner of 80,983 conditional nil-cost Share options under the PSP.

 

Saskia Korink Romani has no direct shareholding in the Company and is the beneficial owner of 37,650 conditional nil-cost Share options under the PSP.

 

Jerry Thompson has no direct shareholding in the Company and is the beneficial owner of 17,545 conditional market value Share options under the ESOP and 48,134 conditional nil-cost Share options under the PSP.

 

Denny Funk has no direct shareholding in the Company and is the beneficial owner of 25,568 conditional market value Share options under the ESOP and 33,576 conditional nil-cost Share options under the PSP.

 

Catherine Glickman's direct shareholding in the Company stands at 1,657 Shares representing 0.003 % of the issued share capital of the Company. In addition, she is the beneficial owner of 44,213 conditional nil-cost Share options under the PSP.

 

Tom Kilroy has no direct shareholding in the Company and is the beneficial owner of 26,539 conditional nil-cost Share options under the PSP.

 

 

 

For further information please contact:

 

Tom Kilroy

Group General Counsel & Company Secretary

Genus plc

 

Tel: 01256 347100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUBABROWAKUAR
Date   Source Headline
16th Jun 20268:28 amRNSHolding(s) in Company
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.